None listed
Conditions
Interventions
Intervention1: Photostable Gold - Sunscreen Gel: Fixed amount of test product will be applied to the skin, then spread over the whole test site using a finger cot. Single application
Intervention2: Ph
Sponsors
Sun Pharmaceutical Industries Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1 - Healthy adult males and non-pregnant or non-lactating females. 2 - Participants with ITA value of at least 28 using Chromameter and be untanned on the test area. 3 - Participants with uniform skin color over the whole test area and with no variation in ITA greater than 5 from each other or the MEDu test area. 4 - Participants with test sites, free from pigmentation, nevi, sunburn and hair. 5 - Participants with test sites, free from pigmentation, nevi, sunburn and hair. 6 - Participants who are free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator. 7 - Participants who are willing to voluntarily participate in the study and provide signed informed consent. 8 - Participants who are willing and able to comply with all study requirements and procedures throughout the study duration.
Exclusion criteria
Exclusion criteria: 1 - Participants with a history of abnormal responses to the sun e.g., phototoxic or photoallergic responses. 2 - Participants with known allergy or sensitivity to cosmetic products and or any ingredients of the test product. 3 - Participants with systemic dermatological conditions including dysplastic nevi. 4 - Participants having marks, blemishes or nevi in the test area. 5 - Participants having excessive hair in the area on the test on the day of testing. Maybe shaved up to 3 days prior to the test day. 6 - Participants presenting existing sun damage in the test area. 7 - Participants who have used tanning beds in the previous eight weeks prior to SPF testing. 8 - Participants who had sun exposure on their back within the eight weeks leading up to the SPF testing. 9 - Participants using medication with photo-sensitizing potential and or anti-inflammatory medication. 10 - Participants having skeletal protrusions and extreme areas of curvature in the test area. 11 - Participants participating in other similar cosmetic or therapeutic study within last eight weeks. 12 - Any other condition which could warrant exclusion from the study, as per the Dermatologist or investigator discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Individual Minimal Erythema DoseTimepoint: Day 05 | — |
Secondary
| Measure | Time frame |
|---|---|
| Delayed Erythema ResponseTimepoint: Day 06 | — |
Countries
India
Contacts
Public ContactDr Parth Joshi
Sun Pharmaceutical Industries Limited
Outcome results
None listed